cladribine
Showing 26 - 50 of 172
Multiple Sclerosis Trial in Latham (Cladribine Tablets)
Recruiting
- Multiple Sclerosis
- Cladribine Tablets
-
Latham, New YorkMultiple Sclerosis Center of Northeastern New York, P.C.
Jan 12, 2022
Czech Pharmaco-epidemiological Study on Disease Modifying Drugs
Completed
- Multiple Sclerosis
- interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
-
Prague, CzechiaIMPULS Endowment Fund
Mar 7, 2023
Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)
Recruiting
- Acute Myeloid Leukemia
- CAV Regimen
- MEC Regimen
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Dec 22, 2022
Relationship Between Oral DMT Burden and Adherence in MS
Enrolling by invitation
- Multiple Sclerosis
- Adherence, Medication
- Cladribine
- +5 more
-
Melbourne, Victoria, AustraliaMonash University
Aug 28, 2022
Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,
Recruiting
- Burkitt Lymphoma
- +2 more
- Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
-
Zhuhai, Guangdong, ChinaThe Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023
Advanced Multiple Sclerosis, Progressive Multiple Sclerosis Trial in United Kingdom (Cladribine (MAVENCLAD®), Placebo)
Recruiting
- Advanced Multiple Sclerosis
- Progressive Multiple Sclerosis
- Cladribine (MAVENCLAD®)
- Placebo
-
Belfast, United Kingdom
- +18 more
Jun 9, 2022
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Cladribine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 18, 2022
Seasonal Influenza Vaccination in Multiple Sclerosis Patients
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Vaccine Response Impaired
- Most recent vaccine to seasonal influenza
-
Duesseldorf, Northrhine-Westphalia, GermanyMedical Faculty, Heinrich-Heine-University
Aug 19, 2021
Secondary Acute Myeloid Leukemia Trial in Houston (Cladribine, Cytarabine, Uproleselan)
Recruiting
- Secondary Acute Myeloid Leukemia
- Cladribine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 25, 2021
Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)
Recruiting
- Leukemia, Monocytic, Acute
- Pediatric AML
- Cladribine
- +5 more
-
Foshan, Guangdong, China
- +8 more
Mar 28, 2022
Acute Myeloid Leukemia MDS Trial in Gliwice (Cladribine)
Not yet recruiting
- Acute Myeloid Leukemia Myelodysplastic Syndromes
- Cladribine
-
Gliwice, PolandKlinika Transplantacji Szpiku i Onkohematologii Narodowy Instytu
May 3, 2021
Multiple Sclerosis Trial in Rouen (biological collection)
Unknown status
- Multiple Sclerosis
- biological collection
-
Rouen, FranceRouen University Hospital
Mar 25, 2021
Lymphoma Trial in Houston (2CdA, Cyclophosphamide, Rituximab)
Completed
- Lymphoma
- 2CdA
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 3, 2022
Langerhans Cell Histiocytosis of Lung Trial in Paris (Cladribine)
Unknown status
- Langerhans Cell Histiocytosis of Lung
- Cladribine
-
Paris, FranceSaint Louis hospital
Feb 17, 2021
Leukemia Trial in Shanghai (CLAM+PBSC)
Suspended
- Leukemia
-
Shanghai, ChinaRui Jin Hospital, Department of Hematology
Nov 23, 2021
Refractory Hematologic Cancer, Allogeneic Stem Cell Transplantation Trial in Shanghai (CLAGE-FluBu)
Active, not recruiting
- Refractory Hematologic Cancer
- Allogeneic Stem Cell Transplantation
-
Shanghai, ChinaBlood & Marrow Transplantation Center, RuiJin Hospital
Nov 23, 2021
Peripheral T-cell Lymphoma Trial in Shanghai (BEAC, Cladribine combined with BEAC)
Recruiting
- Peripheral T-cell Lymphoma
- BEAC
- Cladribine combined with BEAC
-
Shanghai, Shanghai, ChinaRuijin Hospital
May 9, 2021
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)
Completed
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 23, 2022
Acute Leukemia, in Relapse, Acute Leukemia Refractory Trial in Suzhou (CVA regimen bridging to HSCT)
Recruiting
- Acute Leukemia, in Relapse
- Acute Leukemia Refractory
- CVA regimen bridging to HSCT
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Jan 4, 2022
Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)
Completed
- Adult Acute Lymphocytic Leukemia
- Cyclophosphamide
- +20 more
-
Frankfurt, GermanyUniversity of Frankfurt, Medical Dept. II
Aug 17, 2022
First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)
Active, not recruiting
- Multiple Sclerosis
- Cladribine
-
Alexandroupolis, Greece
- +52 more
Sep 28, 2022
Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed Trial in Guangzhou (Cladribine Injection, Aclarubicin, G-CSF)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- Cladribine Injection
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 15, 2020
High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,
Recruiting
- High Risk Acute Myeloid Leukemia
- Allogeneic Hematopoeitic Stem Cell Transplantation
- Cladribine
- +3 more
-
Shanghai, Shanghai, ChinaShanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021
High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,
Recruiting
- High Risk Acute Myeloid Leukemia
- Allogeneic Hematopoeitic Stem Cell Transplantation
- Cladribine
- +3 more
-
Shanghai, Shanghai, ChinaShanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021